← All trials
NCT05758064
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2023
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Mar 7, 2023
- Last posted
- Mar 7, 2023
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- El Shatby University Hospital for Obstetrics and GynecologyLead sponsor
- Alexandria UniversityStudy chair
- El Shatby University Hospital for Obstetrics and GynecologyReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.